KalVista Pharmaceuticals creating a new generation of small molecule protease inhibitors for HAE and DME Hereditary Angioedema (HAE)Diabetic Macular Edema (DME)
News KalVista Pharmaceuticals Provides Update on Diabetic Macular Edema Programs Feb 10, 2020 KalVista Pharmaceuticals Provides Update on Oral Hereditary Angioedema Franchise Jan 13, 2020 KalVista Pharmaceuticals Reports Phase 2 Clinical Trial Results in Patients with Diabetic Macular Edema Dec 9, 2019 All News
KalVista Pharmaceuticals Reports Phase 2 Clinical Trial Results in Patients with Diabetic Macular Edema Dec 9, 2019
